NDMA inson uchun mumkin bo'lgan kanserogen sifatida tasniflanadi. Bu shuni anglatadiki, xavfsiz deb hisoblanadigan darajadan yuqori bo'lgan uzoq muddatli ta'sir saraton xavfini oshirishi mumkin. Kanada sog'liqni saqlash tashkiloti chaqirib olingan APO-Amitriptilin yoki Elavil (amitriptilin) ni qabul qilishni davom ettirishda darhol xavf yo'qligini maslahat beradi, chunki saratonning potentsial xavfi NDMA ning xavfsiz darajadan oshib ketadigan uzoq muddatli (70 yil davomida har kuni) ta'sirida.
Kanada sog'liqni saqlash tizimi ushbu muammodan ta'sirlangan eslab qolingan amitriptilin preparatlari ro'yxatini yuritadi. Iltimos, qo'shimcha ma'lumot, jumladan, xavf va bemorlar nima qilishi kerakligi haqida ko'proq ma'lumot olish uchun to'liq maslahatni ko'ring.
| kompaniya | mahsulot | kuch | Din | lot | Muddati |
| AA Pharma Inc. | Elavil
(Amitriptilin gidroxlorid Planshetlar USP) |
10 mg | 00335053 | PY1829 | 12/2023 |
| AA Pharma Inc. | Elavil (Amitriptilin gidroxlorid Planshetlar USP) |
10 mg | 00335053 | PY1830 | 12/2023 |
| Apotex Inc. | APO-amitriptilin
(Amitriptilin gidroxlorid Planshetlar USP) |
10 mg | 02403137 | PY1832 | 12/2023 |
USHBU MAQOLADAN NIMA OLISH KERAK:
- Health Canada is advising that there is no immediate risk in continuing to take the recalled APO-Amitriptyline or Elavil (amitriptyline) since the potential risk of cancer is with long-term exposure (every day for 70 years) to NDMA that exceeds safe levels.
- .
- .
